Literature DB >> 18080856

MR imaging of brainstem atrophy in progressive supranuclear palsy.

Jerzy Slowinski1, Akiko Imamura, Ryan J Uitti, Robert A Pooley, Audrey J Strongosky, Dennis W Dickson, Daniel F Broderick, Zbigniew K Wszolek.   

Abstract

BACKGROUND: To enhance the sensitivity and specificity of the clinical diagnosis of progressive supranuclear palsy (PSP), neuroradiological parameters established in pathologically proven cases are needed.
METHODS: We examined brainstem atrophy in five pathologically confirmed PSP patients (three men, mean age at death 77 years, range 64-84 years). Time interval between symptom onset and MRI ranged from 1 to 5 years, and between MRI and death from 33 to 52 months. Only one patient had clinical diagnosis of PSP at the time of MRI. Control group consisted of 19 age- and gender-matched healthy subjects. Seventeen morphometric parameters of the midbrain and pons were measured on T1-weighted midsagittal and T2-weighted axial MRI scans with Image Analyzer. Measurements of superior cerebellar peduncle (SCP) width were performed on PSP autopsy specimens.
RESULTS: Mean SCP width on MRI in PSP (2.7 +/- 0.8 mm, 95%CI: 2.1-3.3) was smaller than in controls (3.7 +/- 0.5 mm, 95%CI: 3.5-3.9). Mean SCP width at autopsy was 8% smaller than mean SCP width on MRI. Midsagittal midbrain area in PSP (99.1 +/- 6.9 mm(2), 95%CI: 90.5-107.6) was smaller than in controls (141.0 +/- 18.1 mm(2), 95%CI: 132.2-149.7). Midbrain/pons area ratio in PSP was 1:5 and in controls was 1:4 (p < 0.01). Repeat MRI 17 months later in one PSP case revealed 30% decrease of SCP width.
CONCLUSIONS: MR imaging with quantitative analysis may be useful in the diagnosis of early PSP and in monitoring disease course.

Entities:  

Mesh:

Year:  2007        PMID: 18080856     DOI: 10.1007/s00415-007-0656-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  27 in total

1.  Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy.

Authors:  M Warmuth-Metz; M Naumann; I Csoti; L Solymosi
Journal:  Arch Neurol       Date:  2001-07

2.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

3.  Abnormal signals on proton density-weighted MRI of the superior cerebellar peduncle in progressive supranuclear palsy.

Authors:  M Oka; S Katayama; Y Imon; T Ohshita; Y Mimori; S Nakamura
Journal:  Acta Neurol Scand       Date:  2001-07       Impact factor: 3.209

4.  Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.

Authors:  N J Cordato; A J Duggins; G M Halliday; J G L Morris; C Pantelis
Journal:  Brain       Date:  2005-04-20       Impact factor: 13.501

5.  Morning glory sign: a particular MR finding in progressive supranuclear palsy.

Authors:  Michito Adachi; Toru Kawanami; Humi Ohshima; Yukio Sugai; Takaaki Hosoya
Journal:  Magn Reson Med Sci       Date:  2004-12-15       Impact factor: 2.471

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  Relationship between brainstem MRI and pathological findings in progressive supranuclear palsy--study in autopsy cases.

Authors:  I Aiba; Y Hashizume; M Yoshida; S Okuda; N Murakami; N Ujihira
Journal:  J Neurol Sci       Date:  1997-11-25       Impact factor: 3.181

8.  Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.

Authors:  Adam L Boxer; Michael D Geschwind; Nataliya Belfor; Maria Luisa Gorno-Tempini; Guido F Schauer; Bruce L Miller; Michael W Weiner; Howard J Rosen
Journal:  Arch Neurol       Date:  2006-01

9.  Progressive supranuclear palsy: MRI and pathological findings.

Authors:  A Yagishita; M Oda
Journal:  Neuroradiology       Date:  1996-05       Impact factor: 2.804

10.  MR imaging in progressive supranuclear palsy and Shy-Drager syndrome.

Authors:  M Savoiardo; L Strada; F Girotti; L D'Incerti; M Sberna; P Soliveri; L Balzarini
Journal:  J Comput Assist Tomogr       Date:  1989 Jul-Aug       Impact factor: 1.826

View more
  17 in total

1.  Magnetic resonance imaging in progressive supranuclear palsy.

Authors:  M Stamelou; S Knake; W H Oertel; G U Höglinger
Journal:  J Neurol       Date:  2010-12-22       Impact factor: 4.849

2.  Brainstem atrophy on routine MR study in pallidopontonigral degeneration.

Authors:  Jerzy L Slowinski; Katherine J Schweitzer; Akiko Imamura; Ryan J Uitti; Audrey J Strongosky; Dennis W Dickson; Daniel F Broderick; Zbigniew K Wszolek
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

3.  MRI Planimetry and Magnetic Resonance Parkinsonism Index in the Differential Diagnosis of Patients with Parkinsonism.

Authors:  V C Constantinides; G P Paraskevas; G Velonakis; P Toulas; E Stamboulis; E Kapaki
Journal:  AJNR Am J Neuroradiol       Date:  2018-04-05       Impact factor: 3.825

4.  Clinical correlates of white matter tract degeneration in progressive supranuclear palsy.

Authors:  Jennifer L Whitwell; Ankit V Master; Ramesh Avula; Kejal Kantarci; Scott D Eggers; Heidi A Edmonson; Clifford R Jack; Keith A Josephs
Journal:  Arch Neurol       Date:  2011-06

Review 5.  Recognizing Atypical Parkinsonisms: "Red Flags" and Therapeutic Approaches.

Authors:  Nikolaus R McFarland; Christopher W Hess
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

6.  The Hummingbird sign: a diagnostic clue for Steele-Richardson-Olszweski syndrome.

Authors:  Nikhil Sonthalia; Sayantan Ray
Journal:  BMJ Case Rep       Date:  2012-09-17

Review 7.  Neuroimaging in frontotemporal lobar degeneration--predicting molecular pathology.

Authors:  Jennifer L Whitwell; Keith A Josephs
Journal:  Nat Rev Neurol       Date:  2012-01-31       Impact factor: 42.937

8.  Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology.

Authors:  J L Whitwell; C R Jack; J E Parisi; J L Gunter; S D Weigand; B F Boeve; J E Ahlskog; R C Petersen; D W Dickson; K A Josephs
Journal:  Eur J Neurol       Date:  2013-06-07       Impact factor: 6.089

9.  The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy.

Authors:  Luke A Massey; Hans R Jäger; Dominic C Paviour; Sean S O'Sullivan; Helen Ling; David R Williams; Constantinos Kallis; Janice Holton; Tamas Revesz; David J Burn; Tarek Yousry; Andrew J Lees; Nick C Fox; Caroline Micallef
Journal:  Neurology       Date:  2013-04-24       Impact factor: 9.910

10.  Midbrain atrophy in subcortical ischemic vascular dementia.

Authors:  Young-Hee Sung; Ki-Hyung Park; Yeung-Bae Lee; Hyeon-Mi Park; Dong Jin Shin; Jea-Sul Park; Mi-Sun Oh; Hyeo-Il Ma; Kyung-Ho Yu; Suk-Yun Kang; Yun Joong Kim; Byung-Chul Lee
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.